Guang-xiao Meng
107 West Wen Hua Road
Jinan, 250012, China
Jinan, 250012, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Targeting FAM111B attenuates mitophagy and increases the sensitivity to lenvatinib treatment by increasing MFN2 stability in hepatocellular carcinoma.
Journal: Cell death & disease
Published: February 25, 2025
Correction: MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway.
Journal: Cancer cell international
Published: June 08, 2024
Thyroid hormones inhibit tumor progression and enhance the antitumor activity of lenvatinib in hepatocellular carcinoma via reprogramming glucose metabolism.
Journal: Cell death discovery
Published: April 25, 2024
MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway.
Journal: Cancer cell international
Published: June 12, 2023
Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis.
Journal: Expert review of gastroenterology & hepatology
Published: May 06, 2023
Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity.
Journal: Cell death & disease
Published: January 24, 2023
Systemic therapy with or without locoregional therapy for advanced hepatocellular carcinoma: A systematic review and network meta-analysis.
Journal: Critical reviews in oncology/hematology
Published: January 07, 2023
Early alpha-fetoprotein response predicts prognosis of immune checkpoint inhibitor and targeted therapy for hepatocellular carcinoma: a systematic review with meta-analysis.
Journal: Expert review of gastroenterology & hepatology
Published: December 08, 2022
The Association of Glycemic Index, Glycemic Load, and Daily Carbohydrates Intake with the Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Journal: Nutrition and cancer
Published: November 21, 2022
BRF2 is mediated by microRNA-409-3p and promotes invasion and metastasis of HCC through the Wnt/β-catenin pathway.
Journal: Cancer cell international
Published: November 14, 2022
Evaluating liver function and the impact of immune checkpoint inhibitors in the prognosis of hepatocellular carcinoma patients: A systemic review and meta-analysis.
Journal: International immunopharmacology
Published: September 04, 2022
Last Updated: 09/26/2026